Nature's Sunshine is targeting $1 billion in sales and a 15% EBITDA margin for 2026 [1].
These ambitious targets come as the company seeks to scale its operations and improve profitability through strategic initiatives. The goals signal a push for significant growth beyond current revenue projections.
In its first-quarter 2026 performance report, the company noted that sales grew by 9% [4]. During the same period, EBITDA increased by 33% [5]. These figures suggest a strong start to the year and a trajectory of increasing efficiency.
Despite the long-term $1 billion goal, the company reiterated its revenue outlook for 2026 within a range of $500 million to $515 million [3]. This indicates a phased approach to growth, where immediate yearly targets remain more conservative than the overarching corporate ambition.
CEO Kenneth Romanzi said, "I'm very pleased to report that we delivered a very strong first quarter, growing sales 9% and EBITDA 33%, reflecting continued momentum across our key strategic initiatives."
Management attributed the strong quarterly results to the ongoing success of its strategic initiatives. The company continues to focus on these drivers to bridge the gap between its current revenue outlook and the $1 billion sales target [1].
“Nature's Sunshine is targeting $1 billion in sales and a 15% EBITDA margin for 2026.”
The disparity between the $1 billion target and the $500 million to $515 million revenue outlook suggests that the company is projecting a steep growth curve or planning for significant expansions in the coming years. By maintaining a conservative near-term outlook while setting a high long-term ceiling, Nature's Sunshine is attempting to balance investor expectations with aggressive corporate scaling.
